Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-Arm, Open-Label, Multicenter Phase II Study to Evaluate the Efficacy and Safety of P276-00 in Patients With Relapsed and/or Refractory Mantle Cell Lymphoma

NCT00843050 is registered in ClinicalTrials.gov with Piramal Enterprises Limited as lead sponsor.

NCT NCT00843050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00843050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-Arm, Open-Label, Multicenter Phase II Study to Evaluate the Efficacy and Safety of P276-00 in Patients With Relapsed and/or Refractory Mantle Cell Lymphoma
Lead sponsor
Piramal Enterprises Limited
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2009
Completion date
August 31, 2012
Enrollment
13 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

mantle cell lymphoma